TickerFactsScreenerDevelopers

Kura Oncology, Inc. (KURA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2007: $02009: $11.1K2010: $26.9K2011: $4.2K2012: $4.8K2013: $6.6K2014: $1.12M2015: $15.44M2016: $9.72M2017: $11.43M2018: $16.12M2019: $26.14M2020: $325.49M2021: $90.67M2022: $51.80M2023: $37.32M2024: $224.46M2025: $149.10M$149.10M
2007Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$149.10M-33.6%
2024$224.46M+501.5%
2023$37.32M-28.0%
2022$51.80M-42.9%
2021$90.67M-72.1%
2020$325.49M+1145.4%
2019$26.14M+62.1%
2018$16.12M+41.0%
2017$11.43M+17.6%
2016$9.72M-37.0%
2015$15.44M+1273.9%
2014$1.12M+17013.3%
2013$6.6K+36.8%
2012$4.8K+13.8%
2011$4.2K-84.3%
2010$26.9K+141.4%
2009$11.1K—
2007$0—